Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hvidovre University Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Hepatic steatosis may cause inflammation and fibrosis within the liver potentially leading to end-stage liver disease cirrhosis, liver failure and death. The condition is associated with several other chronic liver diseases like autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, hereditary hemochromatosis and alpha-1-antitrypsin deficiency and may also develop secondary to other diseases like inflammatory bowel disease and chronic pancreatitis. Diagnosing chronic liver diseases can be challenging and treatment may be limited. In-depth phenotyping at a tissue level may generate insight into the underlying pathophysiology of diseases and furthermore identify common as well as specific diagnostic biomarkers and future treatment targets of the diseases. We therefore undertake a study that evaluates patients with chronic liver diseases associated with hepatic steatosis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Identification and validation of a diagnostic classifier enabling discrimination of chronic liver diseases. | OMICS based analyses on plasma and liver tissue | 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| To identify any metabolic disturbances within chronic liver diseases | Collection of plasma during an oral glucose tolerance test measuring pancreatic and gut hormones | Plasma obtained at time point 0 min, 15 min, 30 min, 45 min, 60 min, 90 min, 120 min. |
| Measure | Description | Time Frame |
|---|---|---|
| Fibrosis stage of the liver | Non-invasive scoring systems (e.g. Fibroscan, Fib-4) | 10 years |
Inclusion Criteria:
Exclusion Criteria:
Patients with:
Not provided
Not provided
Not provided
Potentially eligible patients will be identified and recruited among those referred with suspected liver disease at the outpatient clinic at the Gastro Unit, Copenhagen University Hospital Hvidovre, Denmark. Healthy control participants will be recruited through advertisements at forsoegsperson.dk and posters. Posters will be mounted in neutral places at Copenhagen University Hospital Hvidovre and at neutral places at the Panum Institute. Copenhagen University Hospital Hvidovre is a large regional hospital with more than 3500 employees and the Panum Institute is a large building complex in Copenhagen, Denmark that houses the Faculty of Health and Medical Sciences.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Anne-Sofie H Jensen, MD | Contact | +4538621966 | anne-sofie.houlberg.jensen@regionh.dk | |
| Lise L Gluud, Professor | Contact | +4538621964 | lise.lotte.gluud.01@regionh.dk |
| Name | Affiliation | Role |
|---|---|---|
| Lise L Gluud, Professor | Hvidovre University Hospital | Principal Investigator |
| Nicolai J Wewer Albrechtsen, MD, PhD | NNF Center for Protein Research | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hvidovre University Hospital | Recruiting | Hvidovre | 2650 | Denmark |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40671462 | Derived | Jensen AH, Ytting H, Nielsen AB, Werge MP, Rashu EB, Hetland LE, Thing M, Nabilou P, Burisch J, Junker AE, Hobolth L, Mortensen C, Tofteng F, Bendtsen F, Moller S, Vyberg M, Serizawa RR, Winther-Sorensen M, Kellemann JS, Gluud LL, Wewer Albrechtsen NJ. Diagnostics of Autoimmune Hepatitis Enabled by Non-Invasive Clinical Proteomics. Aliment Pharmacol Ther. 2025 Nov;62(9):901-919. doi: 10.1111/apt.70273. Epub 2025 Jul 17. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D065626 | Non-alcoholic Fatty Liver Disease |
| D005234 | Fatty Liver |
| D019693 | Hepatitis, Autoimmune |
| D008105 | Liver Cirrhosis, Biliary |
| D015209 | Cholangitis, Sclerosing |
| D006432 | Hemochromatosis |
| D050500 | Pancreatitis, Chronic |
| D015212 | Inflammatory Bowel Diseases |
| ID | Term |
|---|---|
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D006521 | Hepatitis, Chronic |
| D006505 | Hepatitis |
Not provided
Not provided
Not provided
Not provided
Not provided
Liver tissue, plasma, serum, whole blood.
| D001327 |
| Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D002780 | Cholestasis, Intrahepatic |
| D002779 | Cholestasis |
| D001649 | Bile Duct Diseases |
| D001660 | Biliary Tract Diseases |
| D008103 | Liver Cirrhosis |
| D005355 | Fibrosis |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D002761 | Cholangitis |
| D008664 | Metal Metabolism, Inborn Errors |
| D008661 | Metabolism, Inborn Errors |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D019190 | Iron Overload |
| D019189 | Iron Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D010195 | Pancreatitis |
| D010182 | Pancreatic Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D007410 | Intestinal Diseases |